Silver Book Fact

The use of sodium oxybate (SXB) in fibromylagia patients reduced pain by 30% or more in 54-58% of patients (versus 35.2% for placebo). SXB also reduced fatigue and sleep disturbance.

Russell I, Holman A, Swick T, et al. Sodium Oxybate Reduces Pain, Fatigue, and Sleep Disturbance and Improves Functionality in Fibromyalgia: Results from a 14-week randomized, double-blind, placebo-controlled study. Pain. 2011; 152(5): 1007-17. http://www.ncbi.nlm.nih.gov/pubmed/21397402

Reference

Title
Sodium Oxybate Reduces Pain, Fatigue, and Sleep Disturbance and Improves Functionality in Fibromyalgia: Results from a 14-week randomized, double-blind, placebo-controlled study
Publication
Pain
Publication Date
2011
Authors
Russell I, Holman A, Swick T, et al
Volume & Issue
Volume 152, Issue 5
Pages
1007-17
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Use of stem cells to create neurons could enable the study of the response of human cells to new drugs in vitro, early in the drug development process.  
  • In individuals with persistent low back pain, tanezumab, a humanized anti-nerve growth factor antibody, showed clinical and statistical analgesic efficacy that was superior to placebo and naproxen.  
  • Exercise has shown to be effective in reducing persistent pain from osteoarthritis of the knee.  
  • Subthalamic nuclei deep brain stimulation (STN-DBS) raises pain thresholds in Parkinson’s disease patients.  
  • Nerve growth factor (NGF) has been found to be a major mediator of inflammatory and neuropathic pain and provides a new therapeutic target.